Sees higher cash flow in 2H25. Sees net debt leverage ratio 3.5-4.0x by year-end. Says current business “in lockstep” with FY25 guidance.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL:
- QuidelOrtho says company actions ‘sufficient’ to mitigate tariff impacts
- QuidelOrtho sees FY25 Labs business growth in mid-single digits
- QuidelOrtho says $30M-$40M of tariff impacts to be mitigated by cost actions
- QuidelOrtho backs FY25 adjusted EPS view 2.07-$2.57, consensus $2.34
- QuidelOrtho reports Q1 adjusted EPS 74c, consensus 59c